Valuation: XtalPi Holdings Limited

Capitalization	49.85B 55.74B 7.15B 6.12B 5.69B 5.31B 9.92B 644B 10.64B 65.58B 25.78B 308B 26.81B 26.26B 1,130B	P/E ratio 2025 *	-84.1x	P/E ratio 2026 *	-142x
Enterprise value	49.09B 54.89B 7.04B 6.03B 5.61B 5.23B 9.77B 635B 10.48B 64.58B 25.39B 304B 26.4B 25.86B 1,113B	EV / Sales 2025 *	82.3x	EV / Sales 2026 *	61.1x
Free-Float	39.22%	Yield 2025 *	-	Yield 2026 *	-

More valuation ratios * Estimated data

Chart: XtalPi Holdings Limited

Timeframe

Style

Dynamic Chart

Latest news: XtalPi Holdings Limited

01-08	XtalPi to Raise HK$2.87 Billion via Bond Offering	MT
12-17	XtalPi's CFO Redesignated to Development Adviser	MT
12-17	Xtalpi Holdings Limited Announces Stepping Down of Tam Man Hong as Chief Financial Officer Effective December 31, 2025	CI
12-05	Mirx Holding Company Limited Enters into Memorandum of Understanding with XtalPi Holdings Limited	CI
11-10	XtalPi Holdings Limited Develops and Values Two Innovative Topical Efficacy Ingredients for Hair Loss Prevention and Hair Growth	CI
11-05	XtalPi Unit Enters Collab Contract for Bispecific Antibody Discovery, Development	MT
11-05	XtalPi's unit in strategic collaboration with Lilly to advance bispecific antibody development	RE
11-05	Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development	CI
09/09/25	Xtalpi Inc. Announces Pep08 Receives Regulatory Clearances to Initiate Phase 1 Clinical Trials in Solid Tumor	CI
09/09/25	XtalPi & PharmaEngine hit milestone as PRMT5 inhibitor PEP08 gets trial nod	RE
05/09/25	GoFintech Innovation Attracts Investments From Inkeverse, XtalPi; GoFintech Shares Up 3%	MT
04/09/25	XtalPi Raises HK$2.63 Billion from Share Placement	MT
29/08/25	XtalPi Eyeing HK$2.7 Billion via Share Sale	MT

More news

News in other languages: XtalPi Holdings Limited

30/06/25

Pfizer : collaboration approfondie avec XtalPi dans l'IA

More news

Managers and Directors: XtalPi Holdings Limited

Manager	Title	Age	Since
Li Peng Lai PRN	Corporate Officer/Principal	42	31/12/2014
Jian Ma CEO	Chief Executive Officer	40	26/11/2023
Pei Yu Zhang CTO	Chief Tech/Sci/R&D Officer	42	31/08/2015

Director	Title	Age	Since
Shu Hao Wen CHM	Chairman	45	26/11/2023
Jian Ma BRD	Director/Board Member	40	27/04/2017
Li Peng Lai BRD	Director/Board Member	42	27/04/2017

More insiders

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
XTALPI HOLDINGS LIMITED	+3.27%	+23.92%	+187.78%	-	6.92B
THERMO FISHER SCIENTIFIC, INC.	-1.64%	-0.22%	+9.78%	+4.87%	233B
INTUITIVE SURGICAL, INC.	-3.04%	+0.52%	+5.48%	+121.59%	208B
DANAHER CORPORATION	-0.77%	+0.46%	-1.44%	-13.17%	168B
BOSTON SCIENTIFIC CORPORATION	-2.14%	+0.06%	+0.98%	+104.53%	145B
SIEMENS HEALTHINEERS AG	+0.99%	+4.61%	-7.43%	-4.22%	60.36B
EDWARDS LIFESCIENCES CORPORATION	-2.20%	-1.16%	+17.03%	+7.00%	49.4B
AGILENT TECHNOLOGIES, INC.	-0.81%	+3.04%	+3.75%	-5.89%	42.11B
GE HEALTHCARE TECHNOLOGIES INC.	-1.38%	+1.22%	+0.84%	+31.12%	39.76B
RESMED, INC.	+0.44%	+3.12%	+9.89%	+18.24%	36.78B
Average	-0.76%	+6.22%	+22.67%	+29.34%	98.88B
Weighted average by Cap.	-1.58%	+4.15%	+5.63%	+41.82%

See all sector performances

XtalPi Holdings Ltd, formerly QuantumPharm Inc, is a holding company primarily engaged in the provision of drug and material science research and development solutions and services in the pharmaceutical and material science industries. The Company mainly operates two businesses. The drug discovery solutions business is engaged in providing modular standalone solutions to or collaborating with a diverse range of biotechnology and pharmaceutical companies and academic institutions for novel drug discovery endeavors. The intelligent automation solutions business is engaged in the provision of solid-state research and development services and automated chemical synthesis services. The Company conducts its business in the domestic and overseas markets.

Employees

1,054

Sector

Advanced Medical Equipment & Technology

Calendar

03-26 - Q4 2025 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
12/01/26	12.95 $	+3.27%	203,239,649
09/01/26	12.54 $	+10.48%	161,552,000
08/01/26	11.35 $	-1.65%	101,964,400
07/01/26	11.54 $	+3.59%	117,442,100
06/01/26	11.14 $	+6.60%	122,178,200

Delayed Quote Hong Kong S.E., January 12, 2026 at 08:08 am

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

12.95HKD

Average target price

10.26HKD

Spread / Average Target

-20.80%

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Hong Kong S.E. Other stock markets 08:08:30 12/01/2026 GMT			5-day change	1st Jan Change
12.95 ^HKD	+3.27%		+23.92%	+36.89%

1 day	+3.27%
1 week	+23.92%
Current month	+36.89%
1 month	+36.32%
3 months	+15.11%
6 months	+123.66%
Current year	+36.89%

1 week	10.51	13.5
1 month	9.02	13.5
Current year	9.43	13.5
1 year	3.85	15.12
3 years	3.05	16.2
5 years	3.05	16.2
10 years	3.05	16.2

	2025 *	2026 *
Net sales	596M 667M 85.53M 73.24M 68.11M 63.5M 119M 7.71B 127M 785M 308M 3.69B 321M 314M 13.52B	809M 904M 116M 99.3M 92.35M 86.09M 161M 10.45B 173M 1.06B 418M 5B 435M 426M 18.33B
Net income	-320M -358M -45.9M -39.3M -36.55M -34.08M -63.67M -4.14B -68.29M -421M -166M -1.98B -172M -169M -7.26B	-115M -129M -16.56M -14.18M -13.19M -12.29M -22.97M -1.49B -24.64M -152M -59.71M -714M -62.1M -60.83M -2.62B
Net Debt	-760M -849M -109M -93.27M -86.74M -80.86M -151M -9.82B -162M -999M -393M -4.7B -408M -400M -17.22B	-429M -480M -61.57M -52.72M -49.03M -45.71M -85.41M -5.55B -91.61M -565M -222M -2.65B -231M -226M -9.73B

XtalPi Holdings Limited Share Price

Equities

2228

KYG7S12M1051